Pulse Biosciences
PLSE
48 hedge funds and large institutions have $33.7M invested in Pulse Biosciences in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 3 closing their positions.
11% more capital invested
Capital invested by funds: $30.3M → $33.7M (+$3.42M)
0.18% less ownership
Funds ownership: 11.66% → 11.47% (-0.18%)
6% less funds holding
Funds holding: 51 → 48 (-3)
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Griffin Asset Management
New York
|
+$285K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
+$195K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$129K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$111K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$33.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$453K |
| 2 |
IAN
Integrated Advisors Network
Dallas,
Texas
|
-$155K |
| 3 |
BlackRock
New York
|
-$69.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$68K |
| 5 |
JP Morgan Chase
New York
|
-$54.1K |
PLSE Hedge Fund Activity: Q3 2020 in Review
48 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2020, worth a combined $33.7M — up 11% from $30.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PLSE and 0 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 14 added.
The largest buyer was Griffin Asset Management, adding an estimated $285K. The largest seller was Squarepoint, exiting entirely with an estimated $453K sold.
- 48 institutional investors held Pulse Biosciences (PLSE) as of Q3 2020, down from 51 in Q2 2020.
- Funds reported $33.7M of Pulse Biosciences stock for Q3 2020, up 11% quarter-over-quarter.
- 0 funds opened new Pulse Biosciences positions in Q3 2020 and 3 closed out, a net change of -3 holders.
- The largest Pulse Biosciences buyer in Q3 2020 was Griffin Asset Management, an estimated $285K added.
- The largest Pulse Biosciences seller in Q3 2020 was Squarepoint, an estimated $453K sold.
Based on aggregated 13F filings for Q3 2020.